Showing results (2201-2210 of 2,730) with videos related to

Sort By:
Pageof 273
Journal of Speech, Language, and Hearing Research : JSLHR|April 7, 2017
A Diagnostic Marker to Discriminate Childhood Apraxia of Speech From Speech Delay: II. Validity Studies of the Pause MarkerLawrence D Shriberg, Edythe A Strand, Marios Fourakis, et al.
AIDS (London, England)|October 9, 1998
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapyJ M Raboud, J S Montaner, B Conway, et al.
ACS Medicinal Chemistry Letters|August 16, 2021
Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike ProteinXin Hu, Catherine Z Chen, Miao Xu, et al.
AIDS (London, England)|December 2, 1998
Estimates of the virological benefit of antiretroviral therapy are both assay- and analysis-dependentS Rae, J M Raboud, B Conway, et al.
The Journal of Physiology|October 3, 2002
Cortical spreading depression in the feline brain following sustained and transient stimuli studied using diffusion-weighted imagingDaniel P Bradley, Justin M Smith, Martin I Smith, et al.
Plos One|November 9, 2013
The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 studyLouisa Degenhardt, Alize J Ferrari, Bianca Calabria, et al.
Journal of Neuro-Oncology|September 9, 2020
Intracranial disease control for EGFR-mutant and ALK-rearranged lung cancer with large volume or symptomatic brain metastasesSunil W Dutta, Marie L Mack, Eric Aliotta, et al.
Drug and Alcohol Dependence|September 26, 2020
Availability of substances for use in personal vaporisers on three online cryptomarketsCarmen C W Lim, Janni K Y Leung, Jason P Connor, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|April 7, 2017
A Diagnostic Marker to Discriminate Childhood Apraxia of Speech From Speech Delay: IV. The Pause Marker IndexLawrence D Shriberg, Edythe A Strand, Marios Fourakis, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 14, 2012
The effects on metabolic clearance when administering a potent CYP3A autoinducer with the prototypic CYP3A inhibitor, ketoconazoleMosun A Ayan-Oshodi, Brian A Willis, William F Annes, et al.
Pageof 273